NCT00556374 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 1709
- group Id
- BG001
- value
- 1711
- group Id
- BG002
- value
- 3420
- units
- Participants
- groups
- description
- Participants randomized to receive the matching placebo subcutaneously (SC) once every 6 months (Q6M) in the double-blind phase. All participants continued to receive an approved non-steroidal aromatase inhibitor therapy.
- id
- BG000
- title
- Placebo
- description
- Participants randomized to receive 60 mg denosumab SC once Q6M in the double-blind phase. All participants continued to receive an approved non-steroidal aromatase inhibitor therapy.
- id
- BG001
- title
- Denosumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.0
- value
- 64.6
- group Id
- BG001
- spread
- 7.9
- value
- 64.0
- group Id
- BG002
- spread
- 8.0
- value
- 64.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1709
- group Id
- BG001
- value
- 1711
- group Id
- BG002
- value
- 3420
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1700
- group Id
- BG001
- value
- 1702
- group Id
- BG002
- value
- 3402
- title
- White/Caucasian
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 12
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Hispanic/Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Black/Afro-Caribbean
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 632
- group Id
- BG001
- value
- 633
- group Id
- BG002
- value
- 1265
- title
- Major Academic Center
- categories
- measurements
- group Id
- BG000
- value
- 1077
- group Id
- BG001
- value
- 1078
- group Id
- BG002
- value
- 2155
- title
- Other Center
- param Type
- NUMBER
- title
- Stratification Factor: Type of Hospital
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 269
- group Id
- BG001
- value
- 270
- group Id
- BG002
- value
- 539
- title
- No
- measurements
- group Id
- BG000
- value
- 1440
- group Id
- BG001
- value
- 1441
- group Id
- BG002
- value
- 2881
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Stratification Factor: Prior Aromatase inhibitor Use
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 775
- group Id
- BG001
- value
- 773
- group Id
- BG002
- value
- 1548
- title
- T-score < -1.0
- measurements
- group Id
- BG000
- value
- 934
- group Id
- BG001
- value
- 938
- group Id
- BG002
- value
- 1872
- title
- T-score ≥ -1.0
- description
- T-scores are standardized scores that reflect the standard deviations (SDs) above/below the normal mean for young adults. T-score ≥ -1.0: BMD is considered normal. T-score \< -1.0: Low BMD.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Stratification Factor: Total Lumbar Spine BMD T-score
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 1709
- group Id
- BG001
- value
- 1711
- group Id
- BG002
- value
- 3420
- units
- Participants
- groups
- description
- Participants randomized to receive the matching placebo subcutaneously (SC) once every 6 months (Q6M) in the double-blind phase. All participants continued to receive an approved non-steroidal aromatase inhibitor therapy.
- id
- BG000
- title
- Placebo
- description
- Participants randomized to receive 60 mg denosumab SC once Q6M in the double-blind phase. All participants continued to receive an approved non-steroidal aromatase inhibitor therapy.
- id
- BG001
- title
- Denosumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.0
- value
- 64.6
- group Id
- BG001
- spread
- 7.9
- value
- 64.0
- group Id
- BG002
- spread
- 8.0
- value
- 64.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1709
- group Id
- BG001
- value
- 1711
- group Id
- BG002
- value
- 3420
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1700
- group Id
- BG001
- value
- 1702
- group Id
- BG002
- value
- 3402
- title
- White/Caucasian
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 12
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Hispanic/Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Black/Afro-Caribbean
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 632
- group Id
- BG001
- value
- 633
- group Id
- BG002
- value
- 1265
- title
- Major Academic Center
- categories
- measurements
- group Id
- BG000
- value
- 1077
- group Id
- BG001
- value
- 1078
- group Id
- BG002
- value
- 2155
- title
- Other Center
- param Type
- NUMBER
- title
- Stratification Factor: Type of Hospital
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 269
- group Id
- BG001
- value
- 270
- group Id
- BG002
- value
- 539
- title
- No
- measurements
- group Id
- BG000
- value
- 1440
- group Id
- BG001
- value
- 1441
- group Id
- BG002
- value
- 2881
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Stratification Factor: Prior Aromatase inhibitor Use
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 775
- group Id
- BG001
- value
- 773
- group Id
- BG002
- value
- 1548
- title
- T-score < -1.0
- measurements
- group Id
- BG000
- value
- 934
- group Id
- BG001
- value
- 938
- group Id
- BG002
- value
- 1872
- title
- T-score ≥ -1.0
- description
- T-scores are standardized scores that reflect the standard deviations (SDs) above/below the normal mean for young adults. T-score ≥ -1.0: BMD is considered normal. T-score \< -1.0: Low BMD.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Stratification Factor: Total Lumbar Spine BMD T-score
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle